Global Cellular Health Testing Industry (2020 to 2027) – Growing Popularity of Direct-To-Consumer Approach to Testing Drives Market Demand – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cellular Health Testing – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Amid the COVID-19 crisis, the global market for Cellular Health Testing estimated at US$2.4 Billion in the year 2020, is projected to reach a revised size of US$4.2 Billion by 2027, growing at a CAGR of 8.5% over the period 2020-2027.
Single-Test Panels, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$2.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Multi-Test Panels segment is readjusted to a revised 10.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $695.6 Million, While China is Forecast to Grow at 8% CAGR
The Cellular Health Testing market in the U.S. is estimated at US$695.6 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$729.1 Million by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.
Select Competitors (Total 46 Featured):
- Bio-Reference Laboratories, Inc.
- Cell Science Systems Corp.
- Cleveland Heartlab, Inc.
- Dna Labs India
- Genova Diagnostics
- Immundiagnostik AG
- Laboratory Corporation of America Holdings
- Life Length
- Quest Diagnostics, Inc.
- Repeat Diagnostics Inc. (Repeat Dx)
- Segterra, Inc.
- SpectraCell Laboratories, Inc.
- Telomere Diagnostics, Inc. (Tdx)
- Zimetry LLC
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Cellular Health Testing – Revolutionary Technology Provides Overview of Health at Cellular Level
- North America Projected to Retain Maximum Share in the Market
- Rising Demand for Accurate Telomere Length Test Steers Market Growth
- Digital Transformation in Healthcare to Offer Significant Market Gains
- Focus on Healthy Life Expectancy (HLE) as a Measure of Population Health Promise Growth Opportunities
- Cellular Approach to Tackle Chronic Diseases Ensure Steady Growth Prospects
- Continuous Rise in Geriatric Population Throws Focus on Cellular Heath Screening
- Government Policies and Measures Promoting Preventative Healthcare Augurs Well
- Personalized and Precision Medicine Presents Application Opportunities for Cellular Health Screening
- Growing Popularity of Direct-To-Consumer Approach to Testing Drives Market Demand
- Key Challenges
- Limited Reimbursement
- Challenges in Sample Transportation
- Variation in Pricing of Test Kits
- Covid-19 Impact on Cellular Health Testing Market
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/uoxayy
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
This is a syndicated feed and is brought to you in partnership with Business Wire. mHealth Updates and Trade News Network are not responsible for any claims made in this story.